2-[(1h-Benzimidazol-2-ylmethyl)sulfanyl]-n-(naphthalen-2-yl)acetamide
Common Name: |
2-[(1h-Benzimidazol-2-ylmethyl)sulfanyl]-n-(naphthalen-2-yl)acetamide |
IUPAC Name: |
2-(1H-benzimidazol-2-ylmethylsulfanyl)-N-naphthalen-2-ylacetamide |
Molecular Formula: |
C16H26O2 |
SMILES: |
C1=CC=C2C=C(C=CC2=C1)NC(=O)CSCC3=NC4=CC=CC=C4N |
Inchi: |
1S/C20H17N3OS/c24-20(21-16-10-9-14-5-1-2-6-15(14)11-16)13-25-12-19-22-17-7-3-4-8-18(17)23-19/h1-11H,12-13H2,(H,21,24)(H,22,23) |
Inchi Key: |
UCPAPCWOXXMNFC-UHFFFAOYSA-N |
Cas No: |
5925-75-7 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
250.38 |
Mass (g/mol) |
347.109 |
Molar Refractivity |
73.49 |
Net Charge |
|
HBD |
|
HBA |
2 |
Rt Bonds |
0 |
Rings |
|
TPSA |
26.30 |
Hetero Atoms |
2 |
Heavy Atoms |
18 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
120.00 |
Vapor Pressure (mmHg@25.00 °C) |
18.25 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.94 |
LogP |
1.286 |
iLOGP |
2.80 |
XLOGP3 |
4.32 |
WLOGP |
3.93 |
MLOGP |
3.80 |
ESOL Log S |
-4.11 |
ESOL Solubility (mg/ml) |
0.019 |
ESOL Solubility (mol/l) |
0 |
ESOL Class: esol_class |
Moderately soluble |
Ali Log S |
-4.59 |
Ali Solubility (mg/ml) |
0.01 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-3.90 |
Silicos-IT Solubility (mg/ml) |
0.03 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-4.76 |
Bioavailability Score |
0.55 |
Caco2 |
|
Human Intestinal Absorption |
|
Plasm Protein Binding |
|
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
1 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
|
Acute Oral Toxicity |
|
Carcinogenicity (Binary) |
|
Carcinogenicity (Trinary) |
null |
Eye Irritation |
|
Hepatotoxicity |
|
Androgen Receptor Binding |
|
Aromatase Binding |
|
Estrogen Receptor Binding |
|
Glucocorticoid Receptor Binding |
|
Thyroid Receptor Binding |
|
BRCP inhibitor |
|
BSEP inhibitor |
|
OATP1B1 inhibitor |
|
OATP1B3 inhibitor |
|
OATP2B1 inhibitor |
|
OCT1 inhibitor |
|
OCT2 inhibitor |
|